• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全面心血管风险管理——在实际中意味着什么?

Comprehensive cardiovascular risk management--what does it mean in practice?

作者信息

Erhardt Leif, Moller Robert, Puig Juan García

机构信息

Department of Cardiology, University of Lund, Malmö University Hospital, Sweden.

出版信息

Vasc Health Risk Manag. 2007;3(5):587-603.

PMID:18078010
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2291303/
Abstract

The continued movement away from the treatment of individual cardiovascular (CV) risk factors to managing overall and lifetime CV risk is likely to have a significant impact on slowing the rate of increase in cardiovascular disease (CVD). However, the management of CVD is currently far from optimal even in parts of the world with well-developed and well-funded healthcare systems. Effective implementation of the knowledge, treatment guidelines, diagnostic tools, therapeutic interventions, and management programs that exist for CVD continues to evade us. A thorough understanding of the multifactorial nature of CVD is essential to its effective management. Improvements continue to be made to management guidelines, risk assessment tools, treatments, and care programs pertaining to CVD. Ultimately, however, preventing the epidemic of CVD will require a combination of both medical and public health approaches. In addition to improvements in the "high-risk" strategy, which forms the basis of current CVD management, an increase in the utilization of population-based management strategies needs to be made to attempt to reduce the number of patients falling within the "at-risk" stratum for CVD. This review outlines how a comprehensive approach to CVD management might be achieved.

摘要

从治疗个体心血管(CV)危险因素转向管理整体和终生CV风险的持续转变,可能会对减缓心血管疾病(CVD)的增长率产生重大影响。然而,即使在医疗保健系统发达且资金充足的世界部分地区,CVD的管理目前也远未达到最佳状态。有效实施现有的关于CVD的知识、治疗指南、诊断工具、治疗干预措施和管理计划仍然难以实现。对CVD多因素性质的透彻理解对其有效管理至关重要。针对CVD的管理指南、风险评估工具、治疗方法和护理计划仍在不断改进。然而,最终预防CVD的流行将需要医学和公共卫生方法的结合。除了改进构成当前CVD管理基础的“高风险”策略外,还需要增加基于人群的管理策略的应用,以试图减少处于CVD“风险”阶层的患者数量。本综述概述了如何实现CVD管理的综合方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e31/2291303/ed9b596170c1/vhrm0305-587-08.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e31/2291303/b595c1196ce5/vhrm0305-587-01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e31/2291303/a1b911b33dac/vhrm0305-587-02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e31/2291303/7efbb9564336/vhrm0305-587-03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e31/2291303/4917aed86789/vhrm0305-587-04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e31/2291303/a2ed1a7dc600/vhrm0305-587-05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e31/2291303/708537c2f0ce/vhrm0305-587-06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e31/2291303/393dfcb9707f/vhrm0305-587-07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e31/2291303/ed9b596170c1/vhrm0305-587-08.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e31/2291303/b595c1196ce5/vhrm0305-587-01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e31/2291303/a1b911b33dac/vhrm0305-587-02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e31/2291303/7efbb9564336/vhrm0305-587-03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e31/2291303/4917aed86789/vhrm0305-587-04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e31/2291303/a2ed1a7dc600/vhrm0305-587-05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e31/2291303/708537c2f0ce/vhrm0305-587-06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e31/2291303/393dfcb9707f/vhrm0305-587-07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e31/2291303/ed9b596170c1/vhrm0305-587-08.jpg

相似文献

1
Comprehensive cardiovascular risk management--what does it mean in practice?全面心血管风险管理——在实际中意味着什么?
Vasc Health Risk Manag. 2007;3(5):587-603.
2
Practical dietary interventions to prevent cardiovascular disease suitable for implementation in primary care: an ADAPTE-guided systematic review of international clinical guidelines.适合在初级保健中实施的预防心血管疾病的实用饮食干预措施:一项基于 ADAPTE 指南的国际临床指南系统评价。
Int J Behav Nutr Phys Act. 2023 Jul 28;20(1):93. doi: 10.1186/s12966-023-01463-9.
3
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
4
Current trends in epidemiology of cardiovascular disease and cardiovascular risk management in type 2 diabetes.2型糖尿病中心血管疾病的流行病学现状及心血管风险管理趋势
Metabolism. 2021 Oct;123:154838. doi: 10.1016/j.metabol.2021.154838. Epub 2021 Jul 30.
5
Physician cardiovascular disease risk factor management: practice analysis in Japan versus the USA.医生对心血管疾病风险因素的管理:日本与美国的实践分析
Qual Prim Care. 2013;21(1):51-60.
6
An electronic clinical decision support tool to assist primary care providers in cardiovascular disease risk management: development and mixed methods evaluation.一种协助初级保健提供者进行心血管疾病风险管理的电子临床决策支持工具:开发与混合方法评估
J Med Internet Res. 2009 Dec 17;11(4):e51. doi: 10.2196/jmir.1258.
7
Cardiovascular disease and modifiable cardiometabolic risk factors.心血管疾病与可改变的心脏代谢危险因素
Clin Cornerstone. 2007;8(3):11-28. doi: 10.1016/s1098-3597(07)80025-1.
8
Why are we failing to implement effective therapies in cardiovascular disease?为什么我们未能在心血管疾病中实施有效的治疗方法?
Eur Heart J. 2013 May;34(17):1262-9. doi: 10.1093/eurheartj/ehs481. Epub 2013 Feb 1.
9
Which elderly patients should be considered for anti-hypertensive treatment? An evidence-based approach.哪些老年患者应考虑接受抗高血压治疗?循证方法。
J Hum Hypertens. 1998 Sep;12(9):607-13. doi: 10.1038/sj.jhh.1000674.
10
Preventing cardiovascular disease in the 21st century: therapeutic and preventive implications of current evidence.21世纪心血管疾病的预防:当前证据的治疗和预防意义
Am J Cardiovasc Drugs. 2006;6(2):87-101. doi: 10.2165/00129784-200606020-00003.

引用本文的文献

1
Evaluating Cardiovascular Risk Factors Among Healthcare Professionals in Iran.评估伊朗医疗保健专业人员的心血管危险因素。
Med Sci Monit. 2025 Mar 15;31:e947409. doi: 10.12659/MSM.947409.
2
Hemorrhagic stroke and atherogenic markers - is there any relation?出血性中风与动脉粥样硬化标志物——它们之间有关系吗?
J Family Med Prim Care. 2024 Nov;13(11):5145-5151. doi: 10.4103/jfmpc.jfmpc_756_24. Epub 2024 Nov 18.
3
Ten Americas: a systematic analysis of life expectancy disparities in the USA.《美国的十个地区:对美国预期寿命差异的系统分析》

本文引用的文献

1
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).2007年动脉高血压管理指南:欧洲高血压学会(ESH)和欧洲心脏病学会(ESC)动脉高血压管理特别工作组制定
J Hypertens. 2007 Jun;25(6):1105-87. doi: 10.1097/HJH.0b013e3281fc975a.
2
CARRISMA: a new tool to improve risk stratification and guidance of patients in cardiovascular risk management in primary prevention.CARRISMA:一种改善一级预防中心血管风险管理患者风险分层和指导的新工具。
Eur J Cardiovasc Prev Rehabil. 2007 Feb;14(1):141-8. doi: 10.1097/01.hjr.0000244581.30421.69.
3
Lancet. 2024 Dec 7;404(10469):2299-2313. doi: 10.1016/S0140-6736(24)01495-8. Epub 2024 Nov 21.
4
Treatment with Free Triple Combination Therapy of Atorvastatin, Perindopril, Amlodipine in Hypertensive Patients: A Real-World Population Study in Italy.阿托伐他汀、培哚普利、氨氯地平三联自由联合疗法治疗高血压患者:意大利一项真实世界人群研究
High Blood Press Cardiovasc Prev. 2019 Oct;26(5):399-404. doi: 10.1007/s40292-019-00336-2. Epub 2019 Aug 28.
5
A Community-based Cross-sectional Study of Cardiovascular Risk in a Rural Community of Puducherry.基于社区的本地治里农村社区心血管风险横断面研究。
Heart Views. 2015 Oct-Dec;16(4):131-6. doi: 10.4103/1995-705X.172195.
6
Mobile Phone-Based Lifestyle Intervention for Reducing Overall Cardiovascular Disease Risk in Guangzhou, China: A Pilot Study.中国广州基于手机的生活方式干预以降低总体心血管疾病风险:一项试点研究。
Int J Environ Res Public Health. 2015 Dec 17;12(12):15993-6004. doi: 10.3390/ijerph121215037.
7
Estimation of the cardiovascular risk using World Health Organization/International Society of Hypertension (WHO/ISH) risk prediction charts in a rural population of South India.使用世界卫生组织/国际高血压学会(WHO/ISH)风险预测图表在印度南部农村人群中估算心血管风险。
Int J Health Policy Manag. 2015 Apr 21;4(8):531-6. doi: 10.15171/ijhpm.2015.88.
8
Rethinking risk assessment for emerging technology first-in-human trials.重新思考新兴技术首次人体试验的风险评估。
Med Health Care Philos. 2016 Mar;19(1):125-39. doi: 10.1007/s11019-015-9660-7.
9
Assessing the global burden of ischemic heart disease, part 2: analytic methods and estimates of the global epidemiology of ischemic heart disease in 2010.评估缺血性心脏病的全球负担,第2部分:分析方法及2010年缺血性心脏病全球流行病学估计
Glob Heart. 2012 Dec 1;7(4):331-342. doi: 10.1016/j.gheart.2012.10.003. Epub 2012 Dec 5.
10
Perindopril for control of blood pressure in patients with hypertension and other cardiovascular risk factors: an open-label, observational, multicentre, general practice-based study.培哚普利用于控制高血压及其他心血管危险因素患者的血压:一项开放标签、观察性、多中心、基于全科医疗的研究。
Clin Drug Investig. 2008;28(11):673-86. doi: 10.2165/00044011-200828110-00001.
Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.
《2007年心脏病和中风统计数据更新:美国心脏协会统计委员会及中风统计小组委员会报告》
Circulation. 2007 Feb 6;115(5):e69-171. doi: 10.1161/CIRCULATIONAHA.106.179918. Epub 2006 Dec 28.
4
Epidemic obesity and type 2 diabetes in Asia.亚洲的流行性肥胖与2型糖尿病。
Lancet. 2006 Nov 11;368(9548):1681-8. doi: 10.1016/S0140-6736(06)69703-1.
5
Impact of medication therapy discontinuation on mortality after myocardial infarction.心肌梗死后药物治疗中断对死亡率的影响。
Arch Intern Med. 2006 Sep 25;166(17):1842-7. doi: 10.1001/archinte.166.17.1842.
6
Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus.药物治疗不依从对糖尿病患者住院率和死亡率的影响。
Arch Intern Med. 2006 Sep 25;166(17):1836-41. doi: 10.1001/archinte.166.17.1836.
7
Cost-related medication nonadherence among elderly and disabled medicare beneficiaries: a national survey 1 year before the medicare drug benefit.老年及残疾医疗保险受益人与费用相关的药物治疗不依从情况:医疗保险药品福利实施前一年的全国性调查
Arch Intern Med. 2006 Sep 25;166(17):1829-35. doi: 10.1001/archinte.166.17.1829.
8
Knowing your risk factors for coronary heart disease improves adherence to advice on lifestyle changes and medication.了解自己患冠心病的风险因素有助于提高对生活方式改变和药物治疗建议的依从性。
J Cardiovasc Nurs. 2006 Sep-Oct;21(5):E24-31. doi: 10.1097/00005082-200609000-00015.
9
What's in the CARDS?纸牌里有什么?
Diabet Med. 2006 Jul;23(7):711-4. doi: 10.1111/j.1464-5491.2006.01903.x.
10
Prevalence, treatment, and control of combined hypertension and hypercholesterolemia in the United States.美国高血压合并高胆固醇血症的患病率、治疗与控制情况
Am J Cardiol. 2006 Jul 15;98(2):204-8. doi: 10.1016/j.amjcard.2006.01.079. Epub 2006 May 11.